Prime Therapeutics Closes $1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy And Medical Drug Management Expertise
Prime Therapeutics Closes $1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy And Medical Drug Management Expertise
12/05/22, 1:14 PM
Location
Industry
insurance
Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today finalized the previously announced acquisition of Magellan Rx Management, (Magellan Rx), the pharmacy division of Magellan Health, from Centene Corporation. The agreement unites Prime's strong foundation of pharmacy benefit management (PBM) capabilities with Magellan Rx's industry-leading total specialty drug management expertise to create a diversified pharmacy solutions organization serving commercial markets and government programs.
Company Info
Location
Eagan, Minnesota, United States
Company info
Everything we do is connected to helping people get the medicine they need to feel better and live well. It’s meaningful work and we’ve been doing it for over 24 years.
In the pharmacy benefit management (PBM) industry, we’re different. We’re owned by 18 not-for-profit Blue Cross and Blue Shield health plans. This allows us to control costs and empower our employees to put members first. It’s a successful combination. We have the lowest pharmacy trend in the industry and serve 28+ million members throughout the US.
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Kh
Kh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more